Zipsor (Diclofenac Potassium) Patent Expiration, LOE Window & CMS Spending

Zipsor (Diclofenac Potassium) by Cosette: FDA Orange Book LOE 2029-02-24, 3 AB generics, $661K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorCosette
FDA Application & PathwayN022202 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2029-02-24
Orange Book Patents (*PED Extensions)6 patents (0 *PED)
Active AB-Rated Generic Competitors3
2024 CMS Total Public Spend$661K
2024 Medicare Part D Spend$661K
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel